Vascular CXCR4 Expression – a Novel Antiangiogenic Target in Gastric Cancer?
Barbara Ingold, Eva Simon, Ute Ungethüm et al. · 2010
Read Vascular CXCR4 Expression – a Novel Antiangiogenic Target in Gastric Cancer? by Barbara Ingold, Eva Simon, Ute Ungethüm et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010087.txt.
Description
The authors were Barbara Ingold, Eva Simon, Ute Ungethüm, and others. Their 2010 PLOS ONE study hunted for new drug targets in stomach cancer. They focused on G-protein-coupled receptors, a large family of cell surface switches. Such receptors are strong candidates for cancer prevention and treatment strategies.
Comparing tumors that had spread to lymph nodes with those that had not, they singled out CXCR4. That receptor appeared in blood vessels feeding the cancer. Blocking it might slow new vessel growth, so the authors raise it as a possible antiangiogenic target.
Catalog record
| CREATOR | Barbara Ingold, Eva Simon, Ute Ungethüm et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010087